Diet and chronic haloperidol effects on rat midbrain dopamine neurons

Synapse

Volumn 53, Issue 1, 2004, Pages 1-5

  Hamilton, Margaret E ^a   Freeman, Arthur S ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Antipsychotic drug; Electrophysiology; Glucose; Haloperidol; Substantia nigra; VTA

Indexed keywords

HALOPERIDOL; WATER;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIET; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; GLUCOSE INTAKE; MALE; MESENCEPHALON; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; DIET; DOPAMINE; EATING; ELECTROPHYSIOLOGY; GLUCOSE; HALOPERIDOL; MALE; MESENCEPHALON; MICROELECTRODES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 2542603007     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20028     Document Type: Article

References (23)

1. Baptista T. 1999. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 100:3-16.
2. Baptista T, Lacruz A, Angeles F, Silvera R, de Mendoza S, Mendoza MT, Hernandez L. 2001. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 34:223-231.
3. Bunney BS, Grace AA. 1978. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728.
4. Bunney BS, Walters JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 195:560-571.
5. Chiodo LA, Bunney BS. 1983. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
6. Colangelo V, Di Grezia R, Passarelli F, Musicco M, Pontieri FE, Orzi F. 1997. Differential effects of acute administration of clozapine or haloperidol on local cerebral glucose utilization in the rat. Brain Res 768:273-278.
7. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26:903-912.
8. Dunn-Meynell AA, Routh VH, McArdle JJ, Levin BE. 1997. Low-affinity sulfonylurea binding sites reside on neuronal cell bodies in the brain. Brain Res 745:1-9.
9. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. 1995. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 95:2403-2408.
10. Dwyer DS, Liu Y, Bradley RJ. 1999. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells. Neurosci Lett 274:151-154.
11. Freeman AS, Weddige FK, Lipinski Jr JL. 2001. Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activity. Eur J Pharmacol 431:43-46.
12. Ganguli R. 1999. Weight gain associated with antipsychotic drugs. J Clin Psychiatry 60(Suppl 21):20-24.
13. Grace AA, Bunney BS. 1986. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
14. Jin S, Fredholm BB. 1997. Glucose deprivation increases basal and electrically evoked transmitter release from rat striatal slices. Role of NMDA and adenosine A1 receptors. Eur J Pharmacol 340:169-175.
15. Levin BE. 2000. Glucose-regulated dopamine release from substantia nigra neurons. Brain Res 874:158-164.
16. Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. 2003. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160:290-296.
17. Marinelli S, Bernardi G, Giacomini P, Mercuri NB. 2000. Pharmacological identification of the K(+) currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurons. Neuropharmacology 39:1021-1028.
18. Neusch C, Runde D, Moser A. 2000. G proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals. Neurochem Res 25:1521-1526.
19. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
20. Saller CF, Chiodo LA. 1980. Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science 210:1269-1271.
21. Webb CP, Greenfield SA. 1992. Non-cholinergic effects of acetylcholinesterase in the substantia nigra: a possible role for an ATP-sensitive potassium channel. Exp Brain Res 89:49-58.
22. White FJ, Wang RY. 1983. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057.
23. Zhu DX, Sullivan JP, Brioni JD. 1999. ATP-sensitive potasium channels regulate in vivo dopamine release in rat striatum. Jpn J Pharmacol 79:59-64.